United Kingdom Virtual Wards and Hospital-at-Home Technology Market Size (2026-2030)
The United Kingdom Virtual Wards and Hospital-at-Home Technology Market was valued at approximately USD 412.6 Million. It is projected to grow at a CAGR of around 15.5% during the forecast period of 2026–2030, reaching an estimated USD 848.08 Million by 2030.
The United Kingdom Virtual Wards and Hospital-at-Home Technology Market includes digital technology that allows healthcare services to be delivered to patients at home at a hospital level or under clinically managed care rather than in hospital settings. What is on offer is a range of software platforms, remote monitoring solutions, virtual care technologies, data analytics, and digital infrastructure that facilitate the management of patient pathways virtually. It does not include any income generated from the traditional hospital stays, home care services that are not technology-related, or general healthcare delivery that is not part of virtual ward systems.
The market has become more than just a capacity-management response; it has become a more well-defined part of the healthcare delivery system. With the development of real-time monitoring, data analysis, and streamlined care management, healthcare providers are increasingly embedding remote care into their day-to-day workflows. There is a greater focus on optimizing patient flow, early intervention, minimizing unnecessary hospital use, and having clinical control. Consequently, technology deployments are moving away from single digital products toward platforms that enable scalability, interoperability, and efficiency.
The market is a hub for healthcare transformation and resource optimization for decision-makers. Long-term integration, cyber resilience, clinical workflow integration, and ROI are becoming major priorities in procurement. When organisations consider this market, the factors they need to take into account include the need to meet current operational demands and the future care delivery needs they have, alongside selection, deployment, and ecosystem partnerships in order to ensure the successful growth of virtual care in the United Kingdom.

Key Market Insights
- BCG's new front end, due to be released in 2026, will reduce costs and workload.
- KPMG recommends that those hospital-at-home groups that are ready for 2026 scale carefully and selectively.
- By 2035, providers will be moving to decentralize care with AI, according to PwC.
- IBM discovered that 13% of organizations were compromised in AI models or applications.
- 97% of AI incidents were found to be due to the lack of access controls, according to IBM.
- According to IBM, 14% of healthcare security teams are staffed to the fullest.
- AI assistants will help monitor and support home care and surgery, KPMG said.
- Virtual wards cost the system in 2025, unless they release beds.
- 65% find virtual care easier than face-to-face care.
- Deloitte reports virtual visits rose from 42% to 44% in 2024.
- Twenty-four percent would change doctors if they had the option to see them virtually, meaning there will be even more competition in the physician's office.
- BCG's noted areas for growth included 2024 at-home care, virtual wards, and remote diagnostics.
- Care@Home requires reconfigured devices, since home is not a hospital, says Accenture.
- Accenture associates value-based care stress with decreased-cost home treatment models.

Research Methodology
Scope & Definitions
- Market scope covers technology revenue generated from virtual wards and hospital-at-home platforms, remote patient monitoring solutions, care coordination software, clinical decision support tools, and connected monitoring devices deployed across the United Kingdom.
- Excludes conventional inpatient hospital services, home nursing service revenue, and non-digital community care.
- Analysis covers the United Kingdom with historical, base-year, and forecast assessments using standardized segmentation, inclusion criteria, and a documented data dictionary to prevent overlap and double counting.
Evidence Collection (Primary + Secondary)
- Primary research included interviews across NHS trusts, integrated care systems, technology vendors, device manufacturers, digital health specialists, clinicians, procurement stakeholders, and industry experts.
- Secondary research utilized publications from NHS England, UK Department of Health and Social Care, Office for National Statistics, company reports, investor filings, peer-reviewed literature, and relevant regulators/standards bodies/industry associations specific to the market (named in-report).
- Key findings are supported by verifiable sources and source-linked evidence within the report.
Triangulation & Validation
- Market estimates were developed using bottom-up and top-down methodologies and reconciled against financial disclosures where available.
- Conflicting inputs were resolved through multi-source validation, interview cross-checking, and consistency testing to minimize bias.
Presentation & Auditability
- All assumptions, calculations, segmentation rules, and source references are documented for traceability.
- Findings are presented through auditable tables, forecasts, and evidence-backed insights suitable for decision-grade analysis.

United Kingdom Virtual Wards and Hospital-at-Home Technology Market Drivers
Healthcare providers are focusing on more capacity building using digital means.
In the UK, technology-based care models are becoming a key solution for healthcare providers to cope with the growing demands on services without necessarily building more physical facilities. Virtual care environments help to maximize the utilization of resources and provide ongoing monitoring of patient care. This transformation is driving more investments in connected monitoring, workflow automation, and digitally coordinated care pathways that are helping to make healthcare operations more efficient.
Intelligent clinical workflows are transforming how patients are managed remotely.
Increasing focus on automation in healthcare service delivery is fueling the growth of advanced clinical workflow technologies. Advances in clinical workflow technologies are driving adoption, as healthcare delivery is increasingly focused on automation. Healthcare organizations are looking for systems that simplify the way the patient is monitored, prioritize interventions, and decrease administrative work for care teams. As virtual care programs evolve, intelligent coordination platforms are indispensable for patient management operations that are scalable, efficient, and responsive.
The pace of technology decisions to modernize integrated care is rapidly increasing.
The process of healthcare modernization is driving increased interoperability between care settings, leading to a need for technologies that enable the smooth flow of information and help manage patient data. Decision-makers are increasingly looking for digital platforms that enable them to bring the clinical teams together and monitor the environment and care pathways. This is making technology an enabling platform for future-ready healthcare delivery.
United Kingdom Virtual Wards and Hospital-at-Home Technology Market Restraints
Leaders in the healthcare sector continue to face a myriad of challenges that hinder the growth of virtual care, such as a lack of skilled staff, patient engagement, a disjointed digital landscape, and intricate data-sharing needs. Large-scale deployments can be challenging due to budget constraints, and interoperability issues can add to the operational risk, as can cybersecurity concerns. Achieving a balance between innovation, clinical governance, scalability, and sustainable uptake is increasingly vital to the market's journey.
United Kingdom Virtual Wards and Hospital-at-Home Technology Market Opportunities
There are opportunities for hospital delivery to be extended outside walls, in integrated monitoring ecosystems, predictive clinical intelligence, workforce optimization tools, and scalable digital care pathways. The technologies, partnerships, and services are evolving across the country as a response to the growing demand for proactive chronic disease management, quick discharge coordination, and individualized home-based interventions.
How this market works end-to-end
- Patient Identification
Eligible patients are identified for acute virtual wards, rehabilitation-at-home programs, chronic disease management, or post-discharge monitoring.
- Clinical Assessment
Care teams evaluate clinical suitability, risk levels, monitoring requirements, and escalation protocols.
- Technology Selection
Providers deploy remote patient monitoring platforms, connected devices, and virtual care software based on pathway needs.
- Device Deployment
Monitoring equipment is installed and configured for patient use at home.
- Data Collection
Connected devices continuously collect physiological and clinical information.
- Workflow Coordination
Care coordination platforms route alerts, tasks, and communications across multidisciplinary teams.
- Clinical Monitoring
Healthcare professionals review patient data using virtual care and command-center environments.
- Escalation Management
Clinical decision support tools identify deterioration risks and trigger intervention workflows.
- Care Transition
Patients move from acute monitoring into recovery, rehabilitation, community care, or discharge.
- Performance Evaluation
Providers assess utilization, outcomes, operational efficiency, and technology effectiveness.
Why this market matters now
The strategic question is no longer whether healthcare can be delivered at home. The question is how to scale it safely, efficiently, and sustainably.
NHS organizations continue to face capacity constraints, workforce pressures, and growing demand complexity. Virtual wards offer a pathway to expand care delivery without relying solely on additional physical beds.
However, scaling introduces new risks. Technology fragmentation can create operational inefficiencies. Cybersecurity threats increase as more connected devices and cloud platforms enter clinical environments. Procurement decisions made today may shape operational flexibility for years.
As virtual wards mature, buyers must evaluate not only technology functionality but also interoperability, workflow integration, clinical governance, and vendor resilience.
What matters most when evaluating claims in this market
|
Claim type
|
What good proof looks like
|
What often goes wrong
|
|
Capacity improvement
|
Operational deployment evidence across care pathways
|
Assuming pilots represent scaled performance
|
|
Cost reduction
|
Documented workflow and utilization outcomes
|
Ignoring implementation costs
|
|
Clinical effectiveness
|
Real-world patient monitoring results
|
Overreliance on small studies
|
|
Platform scalability
|
Multi-site deployment experience
|
Confusing deployments with active utilization
|
|
Cybersecurity readiness
|
Established governance and security controls
|
Treating compliance as security
|
|
Integration capability
|
Proven interoperability across systems
|
Assuming APIs guarantee integration
|
The decision lens
1. Define Care Objectives
Identify whether goals focus on admission avoidance, step-down care, rehabilitation, or chronic disease management.
2. Validate Workflow Fit
Compare technology capabilities against actual clinical workflows rather than feature lists.
3. Assess Integration Risk
Review interoperability requirements across electronic records, monitoring systems, and operational platforms.
4. Stress-Test Scalability
Evaluate whether solutions perform beyond pilot environments and support wider deployment.
5. Examine Cyber Resilience
Verify governance, security controls, monitoring processes, and incident response readiness.
6. Compare Vendor Stability
Assess long-term product investment, implementation support, and ecosystem partnerships.
7. Monitor Timing Signals
Track procurement priorities, funding visibility, workforce constraints, and operational pressures.
The contrarian view
A common mistake is treating virtual wards as a device market. In practice, workflow orchestration often creates more value than hardware.
Another error is using patient monitoring volumes as a proxy for market maturity. Large deployments do not automatically indicate operational success.
Many analyses also double count technology categories by combining software, devices, services, and care delivery revenues within the same estimate.
Perhaps the biggest misconception is assuming every clinical pathway benefits equally from virtual ward deployment. Suitability varies significantly across patient groups and care models.
Practical implications by stakeholder
NHS Trusts
- Prioritize interoperability and operational scalability.
- Evaluate long-term workforce implications.
Integrated Care Systems
- Align virtual ward investments across regional care pathways.
- Reduce fragmentation between providers.
Technology Vendors
- Demonstrate workflow outcomes, not just technical features.
- Strengthen integration capabilities.
Device Manufacturers
- Focus on usability and deployment efficiency.
- Support secure data exchange.
Community Healthcare Providers
- Prepare for expanded monitoring responsibilities.
- Coordinate closely with acute care teams.
Healthcare Investors
- Monitor platform adoption and ecosystem consolidation.
- Assess vendor positioning within NHS procurement priorities.
UNITED KINGDOM VIRTUAL WARDS AND HOSPITAL-AT-HOME TECHNOLOGY MARKET REPORT COVERAGE:
|
REPORT METRIC
|
DETAILS
|
|
Market Size Available
|
2025 - 2030
|
|
Base Year
|
2025
|
|
Forecast Period
|
2026 - 2030
|
|
CAGR
|
15.5%
|
|
Segments Covered
|
By Technology Component , Care Model , Clinical Use Case , Healthcare Provider Type , Deployment Model , and Region
|
|
Various Analyses Covered
|
Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
|
|
Regional Scope
|
Europe, UK
|
|
Key Companies Profiled
|
Doccla, Huma, Graphnet Health, Docobo Ltd, Inhealthcare, Feebris, Philips Healthcare, Masimo, Dignio, BT Group, Current Health (Best Buy Health), Lenus Health, Cera Care, The Access Group, and Luscii (Omron Healthcare).
|
United Kingdom Virtual Wards and Hospital-at-Home Technology Market Segmentation
United Kingdom Virtual Wards and Hospital-at-Home Technology Market – By Technology Component
- Introduction/Key Findings
- Remote Patient Monitoring (RPM) Platforms
- Virtual Care & Telehealth Platforms
- Care Coordination & Workflow Management Software
- Clinical Decision Support & AI Analytics Solutions
- Medical Devices & Connected Monitoring Equipment
- Others
- Y-O-Y Growth Trend & Opportunity Analysis
In 2026, Remote Patient Monitoring (RPM) Platforms accounted for more than one-quarter of the technology component share, bolstered by the constant demand for patient monitoring, real-time vital-signs tracking, and their broad adoption in virtual wards within the NHS.
The Clinical Decision Support & AI Analytics Solutions technology is the fastest-growing segment with a projected 24.7% CAGR from 2021 to 2030. Providers are looking for predictive insights, automated risk stratification, and intervention planning, driving demand.
United Kingdom Virtual Wards and Hospital-at-Home Technology Market – By Care Model

- Introduction/Key Findings
- Acute Virtual Wards
- Step-Down/Post-Discharge Virtual Wards
- Admission Avoidance Hospital-at-Home Programs
- Rehabilitation-at-Home Programs
- Palliative & End-of-Life Virtual Care Programs
- Others
- Y-O-Y Growth Trend & Opportunity Analysis
In 2026, acute virtual wards had the highest level of care model usage, at 34.6 percent, driven by increased capacity management, inpatient avoidance strategies, and better use of healthcare delivery networks.
The CAGR for Admission Avoidance Hospital-at-Home Programs is expected to be 25.3% up to 2030. These models are becoming more popular in the healthcare industry as a way to decrease admissions, make better use of resources, and enhance patient satisfaction.
United Kingdom Virtual Wards and Hospital-at-Home Technology Market – By Clinical Use Case
- Introduction/Key Findings
- Respiratory Conditions
- Cardiovascular Conditions
- Frailty & Elderly Care
- Post-Surgical Recovery
- Oncology Care
- Infectious Diseases
- Chronic Disease Management
- Others
- Y-O-Y Growth Trend & Opportunity Analysis
United Kingdom Virtual Wards and Hospital-at-Home Technology Market – By Healthcare Provider Type
-
Introduction/Key Findings
- NHS Acute Hospital Trusts
- Community Healthcare Providers
- Integrated Care Systems (ICSs)
- Mental Health & Specialist Trusts
- Independent Healthcare Providers
- Others
- Y-O-Y Growth Trend & Opportunity Analysis
United Kingdom Virtual Wards and Hospital-at-Home Technology Market – By Deployment Model
- Introduction/Key Findings
- Cloud-Based Solutions
- Hybrid Deployment Solutions
- On-Premises Solutions
- Others
- Y-O-Y Growth Trend & Opportunity Analysis
United Kingdom Virtual Wards and Hospital-at-Home Technology Market– Regional Analysis
The regional lead was 78% for England, thanks to its wide rollout in the NHS's virtual wards, its advanced digital infrastructure, and national adoption across acute and community care settings.
The highest regional market share is from Scotland, with 10% growth and showing signs of accelerating adoption. Investment in the digital modernization of healthcare, remote monitoring, and integrated care delivery models remains robust, bolstering long-term growth prospects.
Latest Market News
On 18 March NHS England announced that virtual ward services are continuing to run on over 10,000 virtual beds, with systems expected to be 80% or more filled under planning guidance for 2025/26. The update further reinforced the importance of remote monitoring and hospital-at-home pathways for both adults and pediatrics.
Health and social care providers are set to benefit from a strategic partnership between Septiscience, maker of Graphnet Health, and Luscii, which will enable them to access Graphnet Remote Monitoring across 20 NHS Integrated Care Systems, covering around 17 million people. The platform already had over 75,000 NHS patients and over 400,000 patients in Europe.
On 14th August 2025, NHS England published July 2025 virtual ward capacity figures, which is the latest in ongoing monitoring of virtual ward occupancy and usage levels in integrated care systems (ICS). The program continued to be in line with planning targets for both adult and children's services and had a planned occupancy of over 80%.
Capacity for June 2025 virtual wards has been published by NHS England, marking the ongoing growth of capacity within local health systems. The guidance highlighted the need to match the priorities for neighborhood health in 2025/26 and to support admission avoidance and early discharge pathways.
NSH England published March 2025 virtual ward performance statistics within its national monitoring framework on the 10th of April 2025. The program remained in place, providing care delivery beyond hospitals, despite operating beyond occupancy targets of > 80% and the need to sustain long-term capacity growth targets.
The Scottish Government announced a target of increasing the capacity of Hospital at Home services by 2,000 beds by the end of 2026 with an extra £100m investment. The goal of the program is to improve the delivery of acute care at home and decrease delayed hospital discharge.
In October 2024, Northamptonshire Integrated Care Board (NICB) recorded 42.5 virtual ward beds per 100,000 people, NHS virtual ward occupancy data revealed. Five other ICBs had between 30.6 and 35.1 beds per 100,000 residents.
On 16th May 2024, NHS England published that the use of virtual wards saved around 9,000 hospital admissions in the South East over the last 12 months. The program was helping to promote wider use of virtual care and facilitate patient flow and de-escalate physical hospital capacity.
Key Players
- Doccla
- Huma
- Graphnet Health
- Docobo Ltd
- Inhealthcare
- Feebris
- Philips Healthcare
- Masimo
- Dignio
- BT Group
Questions buyers ask before purchasing this report
How mature is the United Kingdom virtual wards technology market?
Market maturity varies across technologies, care pathways, and provider types. Some virtual ward models have moved into routine operations, while others remain at earlier deployment stages. Buyers need visibility into where adoption is accelerating, which technologies are becoming standard, and where operational barriers continue to limit scale.
Which technology categories are attracting the most attention?
Buyer focus increasingly extends beyond monitoring devices. Care coordination software, workflow orchestration tools, clinical decision support platforms, and integrated virtual care systems are receiving growing attention because they directly influence operational effectiveness and scalability.
What risks should procurement teams evaluate?
Procurement teams should assess interoperability limitations, cybersecurity exposure, implementation complexity, vendor concentration, and scalability constraints. Technology selection decisions often create long-term operational dependencies that become difficult to reverse.
How important is deployment model selection?
Deployment choices influence security, integration complexity, implementation speed, operational flexibility, and future expansion opportunities. The optimal model depends on organizational priorities, infrastructure readiness, and governance requirements.
Which care pathways are creating the strongest demand?
Demand is strongest where providers can improve capacity utilization, support admission avoidance, accelerate discharge pathways, and manage chronic conditions more effectively. However, suitability differs significantly across patient populations and clinical objectives.
What separates successful virtual ward deployments from unsuccessful ones?
Success typically depends on workflow design, clinical governance, staff engagement, escalation management, and technology integration. Organizations that focus only on device deployment often struggle to achieve expected operational outcomes.
How should buyers evaluate vendor positioning?
Buyers should examine implementation capabilities, integration experience, product roadmap strength, cybersecurity maturity, and long-term commitment to healthcare markets. Feature comparisons alone rarely provide a complete picture.
Why is market intelligence important now?
Decision-makers face evolving procurement priorities, changing care delivery models, growing cybersecurity expectations, and increasing operational pressure. Reliable market intelligence helps reduce uncertainty, identify emerging risks, and improve strategic planning decisions.